ORBIMED ADVISORS LLC 13D and 13G filings for Xenon Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 5:09 pm Sale | 2021-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE | ORBIMED ADVISORS LLC | 631,000 1.220% | -1,080,305 (-63.13%) | Filing |
| 2021-02-12 5:13 pm Purchase | 2020-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE | ORBIMED ADVISORS LLC | 1,711,305 4.890% | 1,076,493 (+169.58%) | Filing |